Increasing Capacity

Capacity

There is a critical need to empower clinical researchers in Low- and Middle-Income Countries (LMICs) to lead the research response to epidemic infections. We offer a portfolio of research capacity building initiatives to support emerging clinical researchers in exchanging knowledge, gaining confidence in their research and leadership skills, developing local and regional research agendas, and ultimately increasing the international footprint of their institution both within ISARIC and further afield. 

Collaboration is at the core of everything we do and our research capacity strengthening programmes focus on reaching out to, and working with a number of regional and international initiatives. Learn more about past and ongoing opportunities. 

Clinical Research During Outbreaks (CREDO)

The CREDO training provides trainees with a set of skills to lead the research response in an outbreak, and strengthens the national capacities of LMICs to generate clinical evidence during outbreaks and facilitate networking and the sharing of resources.

Fellowship Programme

 

Latest news

International Collaboration Establishes the First Core Outcome Measurement Set for Dengue

International Collaboration Establishes the First Core Outcome Measurement Set for Dengue

A major international collaboration between ISARIC researchers at King’s College London and the Oxford University Clinical Research Trials Unit (OUCRU) has created the first global Core Outcome Measurement Set (COMS) for dengue clinical trials.

Launch of the ISARIC Leadership Programme for Scientists

Launch of the ISARIC Leadership Programme for Scientists

The inaugural ISARIC Leadership Programme for Scientists (ILPS) has officially launched, offering mid-career researchers from Low- and Middle-Income Countries (LMICs) the essential skills to become independent research leaders.

Bubonic Plague Treatment Proven Highly Effective and Safe in Global First

Bubonic Plague Treatment Proven Highly Effective and Safe in Global First

Researchers from the UK and Madagascar, in collaboration with Madagascar’s health services and national plague programme, have conducted the world’s first rigorous clinical trial of treatments for bubonic plague.